In the context of COPD–CPA, IL-1β thresholds of 2 pg/mL and 20.3 pg/mL have been reported for monitoring and prognostication; the former signals poorer outcomes and the latter defines a higher activity tier, underscoring that cutoff selection depends on study objectives (129, 130). The gene discussed is IL1B; the disease is chronic obstructive pulmonary disease.